학술논문
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
Document Type
Article
Author
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, November 2021, 9(11):1288-1298)
Subject
Language
English
ISSN
22132619
22132600
22132600